Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding | 1.43% | $208.32M | $540.24B | 90.62% | 81 Outperform | |
| Roche Holding AG | 1.10% | $159.26M | CHF294.92B | 46.38% | 73 Outperform | |
| AstraZeneca | 1.02% | $148.85M | £240.67B | 32.62% | 80 Outperform | |
| HSBC Holdings | 0.99% | $143.82M | £218.16B | 37.91% | 80 Outperform | |
| Shell (UK) | 0.90% | $130.65M | £162.01B | 7.18% | 73 Outperform | |
| Nestlé SA | 0.89% | $129.12M | CHF199.86B | 12.90% | 71 Outperform | |
| Royal Bank Of Canada | 0.84% | $122.63M | $236.25B | 41.64% | 75 Outperform | |
| Novartis | 0.75% | $109.06M | $316.32B | 54.69% | 80 Outperform | |
| Toyota Motor | 0.72% | $104.68M | ¥48.39T | 36.44% | 80 Outperform | |
| Mitsubishi UFJ Financial Group | 0.68% | $98.85M | ¥32.17T | 51.62% | 76 Outperform |